Statement of Retraction: Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling
- PMID: 38376902
- PMCID: PMC11633178
- DOI: 10.1080/21655979.2024.2299625
Statement of Retraction: Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling
Retraction of
-
Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling.Bioengineered. 2022 Jan;13(1):1377-1387. doi: 10.1080/21655979.2021.2017611. Bioengineered. 2022. Retraction in: Bioengineered. 2024 Dec;15(1):2299625. doi: 10.1080/21655979.2024.2299625. PMID: 34974801 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous